Silo Pharma Raises $815K Through Private Placement of Common Stock and Pre-Funded Warrants
Silo Pharma, Inc. entered into securities purchase agreements with accredited investors on November 5, 2026 for a private placement resulting in gross proceeds of approximately $850,000. The transaction included 136,005 shares of common stock at $1.50 per share and pre-funded warrants to purchase up to 430,661 shares at $1.4999 per warrant, exercisable at $0.0001 per share. The private placement closed on November 6, 2026, with net proceeds of approximately $815,000 after deducting placement agent fees and expen...
Key takeaways
Private placement raised approximately $815,000 in net proceeds through issuance of 136,005 common shares and 430,661 pre-funded warrants.
Pre-funded warrants are immediately exercisable at a nominal exercise price of $0.0001 per share, subject to beneficial ownership limitations of 4.99% or 9.99%.
Company entered into a registration rights agreement requiring filing of a registration statement within 30 days and effectiveness within 60 days (or 90 days for SEC full review).
Transaction was conducted pursuant to Section 4(a)(2) under the Securities Act and Regulation D exemptions.
Use of proceeds designated for working capital and general corporate purposes.
Primary source
TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.
Open SEC filingFollow SILO in real time
Get material earnings, filing, IR, and earnings-call alerts by email.